Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of cDNA microarray for expression profiling of estrogen-responsive genes.

A Inoue1, N Yoshida, Y Omoto

  • 1Division of Endocrinology, Saitama Cancer Center Research Institute, 818 Komuro, Ina-machi, Kitaadachi-gun, Saitama-ken 362-0806, Japan.

Journal of Molecular Endocrinology
|October 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-6 in a pleomorphic type of malignant fibrous histiocytoma presenting high fever.

Human pathology·1998
Same author

The effect of pentoxifylline (PTX) on Theiler's murine encephalomyelitis (TMEV)-induced demyelinating disease.

Cellular immunology·1998
Same author

Biomechanical effect and clinical application of the hip joint moment reduction brace.

Clinical orthopaedics and related research·1998
Same author

Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.

Brain research. Molecular brain research·1998
Same author

Modified Chiari osteotomy for arthrosis after Perthes' disease. 14 hips followed for 2-12 years.

Acta orthopaedica Scandinavica·1998
Same author

Endothelins inhibit mineralization of rat calvarial osteoblast-like cells.

Journal of cardiovascular pharmacology·1998
Same journal

A Computational Systems Biology View on the Role of the Menstrual Cycle in Endocrine Health and Disease.

Journal of molecular endocrinology·2026
Same journal

Pancreatic β-cell aging in physiology and diabetes: emerging roles of m6A mRNA methylation.

Journal of molecular endocrinology·2026
Same journal

Neuroendocrine regulation of female fertility: the role of CNS-derived hormones.

Journal of molecular endocrinology·2026
Same journal

Hypothalamic neuropeptides as modulators of neural activity and behaviour.

Journal of molecular endocrinology·2026
Same journal

Massively parallel functional genomic assays in endocrinology: from promise to delivery.

Journal of molecular endocrinology·2026
Same journal

TSH promotes chemerin/CMKLR1-cAMP/ERK-DIO2 signaling in primary rat ependymal cells in vitro.

Journal of molecular endocrinology·2026
See all related articles

This study identifies early and late estrogen-responsive genes in breast cancer cells, revealing key molecular mechanisms of estrogen signaling. Findings aid in understanding cancer development and predicting therapeutic responses.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Estrogen is crucial in physiological processes, including carcinogenesis and breast cancer development.
  • The precise molecular mechanisms of estrogen signaling in cancers remain unclear, necessitating improved therapeutic prediction for breast cancer.

Purpose of the Study:

  • To elucidate estrogen-responsive gene expression profiles in breast cancer.
  • To identify early and late estrogen-responsive genes.
  • To analyze the effects of estrogen antagonists on gene expression and explore estrogen's role across various cancer types.

Main Methods:

  • Estrogen-responsive expression profiling of ~9000 genes in MCF-7 breast cancer cells.
  • Development and application of a custom cDNA microarray for detailed gene subset analysis.

Related Experiment Videos

  • Analysis of gene expression time courses, effects of estrogen antagonists (ICI 182780, 4-hydroxytamoxifen), and hierarchical clustering across multiple cancer cell lines.

    • Main Results:

    • Estrogen-responsive genes were categorized into early and late responders.
    • ICI 182780 abolished most estrogen-regulated genes, while 4-hydroxytamoxifen showed partial effects on some.
    • Estrogen influenced gene expression in cell lines beyond MCF-7, including those from ovarian and stomach cancers.

    Conclusions:

    • Identified specific estrogen-responsive genes provide insights into cancer biology.
    • Understanding these gene expression patterns can contribute to more accurate therapeutic predictions in cancer treatment.
    • Estrogen signaling pathways show complex regulation and potential therapeutic targets across diverse cancer types.